In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Avanos Medical Inc.

www.avanos.com

Latest From Avanos Medical Inc.

Gottlieb Points To Breakthrough And Localized Therapy Devices For Non-Opioid Pain Control

In one of his last public appearances as US FDA commissioner, Scott Gottlieb identified new opioid-alternative medtech products in the regulatory pipeline that provide distraction therapy and thermal management for pain relief. The agency chief also pointed to old-school devices that provide localized delivery of analgesic drugs as effective opioid-substitute or opioid-reducing devices.

Companies Emerging Markets

Eight Products Enter US FDA’s Opioid Challenge

After spending the past six months receiving and reviewing hundreds of product applications, US FDA has decided to select eight promising devices and diagnostics to help tackle the opioid crisis.

Regulation FDA

Avanos/Halyard Tops Recent Medtech CEO-To-Worker Pay Ratio Disclosures

While most device companies filing 2017 annual reports in the first half of 2018 showed CEO-to-worker pay ratios averaging 219:1, Halyard Health (recently renamed Avanos Medical) CEO Joseph F. Woody was compensated 1,250 times what the company’s median employee earned, according to recent disclosures. Medtech Insight also examined CEO-to-worker pay ratios at Align Technologies, Abbott Laboratories, Danaher and Bio-Rad Laboratories, among other firms.

Leadership Companies

Market Intel: Insulin Pumps Dominate $7bn-Plus Global Infusion Devices Market

The global infusion drug delivery market continues to be driven by the rising prevalence of chronic disease and associated obesity, coupled with a growing aging population. Technological advancements such as less invasive pumps, needlestick prevention features and miniaturization have also supported the growing demand, but obstacles such as safety and security issues remain. According to a new report by Meddevicetracker, the global market for infusion pumps and disposables will reach $9.9bn by 2022, a CAGR of 6.4% from 2017. This article takes an in-depth look at the overall infusion pumps market, and dives deeper into the three fastest-growing segments – insulin, enteral and disposable pumps – highlighting the key players and competitive landscape.

Metabolic Market Intelligence
See All

Company Information

  • Industry
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Surgical Sealants
  • Therapeutic Areas
  • Gastrointestinal
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Kimberly-Clark Health Care
  • Halyard Health Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Avanos Medical Inc.
  • Senior Management
  • Joseph F Woody, CEO
    Warren Machan, SVP, Bus. Strategy & Interim CFO
    Mizanu Kebede, SVP, Global Quality Assurance & Reg. Affairs
    Lee Burnes, SVP, Global R&D, Clinical & Medical Affairs
  • Contact Info
  • Avanos Medical Inc.
    Phone: (844) 425-9273
    5405 Windward Pkwy.
    Ste. 100 South
    Alpharetta, GA 30004
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register